Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.58USD
5:26pm GMT
Change (% chg)

$0.01 (+2.47%)
Prev Close
$0.57
Open
$0.60
Day's High
$0.63
Day's Low
$0.58
Volume
4,199
Avg. Vol
16,896
52-wk High
$1.81
52-wk Low
$0.36

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.131
Dec 0.00 -0.143
Sep 0.00 -0.177
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
FY 2016 Jun '16 0.00 -0.333
Mar '16 0.00 -0.103
Dec 0.00 -0.241
Sep 0.00 -0.153
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Jun-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.11 -0.11 -0.11 --
Year Ending Jun-18 1 -0.54 -0.54 -0.54 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 9.36 17.32
P/E High - Last 5 Yrs. -- 18.31 23.07
P/E Low - Last 5 Yrs. -- 4.80 11.49
Beta 1.80 1.07 1.37
Price to Sales (TTM) -- 9.13 10.24
Price to Book (MRQ) -- 10.35 2.61
Price to Tangible Book (MRQ) 2.49 10.52 3.08
Price to Cash Flow (TTM) -- 2.64 15.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 3.06 2.47
Dividend Yield - 5 Year Avg -- 3.11 2.22
Dividend 5 Year Growth Rate -- 6.11 25.03
Payout Ratio(TTM) -- 28.91 32.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 120.37 16.58
Sales (TTM) vs TTM 1 Yr. Ago -- 133.41 7.89
Sales - 5 Yr. Growth Rate -- 28.95 13.99
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.14 193.56 22.47
EPS (TTM) vs TTM 1 Yr. Ago 24.39 -- --
EPS - 5 Yr. Growth Rate -- 5.03 10.30
Capital Spending - 5 Yr. Growth Rate -- 67.37 2.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.48 0.21
Current Ratio (MRQ) 4.30 74.49 1.99
LT Debt to Equity (MRQ) 0.00 34.14 32.55
Total Debt to Equity (MRQ) 0.00 38.04 67.25
Interest Coverage (TTM) -- 140.31 13.52

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.24 3.05
Gross Margin - 5 Yr. Avg. -- 47.24 3.01
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 32.89 46.93
Operating Margin (TTM) -- 61.33 40.22
Operating Margin - 5 Yr. Avg. -- 102.66 39.88
Pre-Tax Margin (TTM) -- 61.86 40.56
Pre-Tax Margin - 5 Yr. Avg. -- 102.92 40.27
Net Profit Margin (TTM) -- 60.22 32.04
Net Profit Margin - 5 Yr. Avg. -- 101.91 31.90
Effective Tax Rate (TTM) -- 5.95 21.45
Effective Tax Rate - 5 Yr. Avg. -- 3.41 20.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 47,036,568 42,303,769
Net Income/Employee (TTM) -2,784,580 38,710,468 12,342,624
Receivable Turnover (TTM) -- 12.36 9,163.37
Inventory Turnover (TTM) -- 5.05 0.97
Asset Turnover (TTM) 0.00 0.18 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -148.65 6.51 2.76
Return on Assets - 5 Yr. Avg. -- -2.20 2.76
Return on Investment (TTM) -184.98 7.61 0.45
Return on Investment - 5 Yr. Avg. -- 9.92 0.43
Return on Equity (TTM) -- 9.70 16.27
Return on Equity - 5 Yr. Avg. -- 12.14 18.59
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 26.35 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.74%
# of Holders: 14
Total Shares Held: 3,079,955
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.